Skip to main content
. 2020 Aug;82(3):469–476. doi: 10.18999/nagjms.82.3.469

Table 2.

Comparison of patients with and without pneumococcal vaccination

Pneumococcal
vaccination (+)
(n=63)
Pneumococcal
vaccination (–)
(n=79)
P
Age, years 76 (65–91) 76 (66–99) 0.990
Sex (female:male) 33:30 31:48 0.130
Smoking history (never/past+current) 31/32 31/48 0.307
Comorbidities
Chronic respiratory disease 26 (41.3%) 9 (11.5%) <0.001
Cardiovascular disease 15 (23.8%) 12 (15.2%) 0.205
Collagen vascular disease 1 (1.6%) 4 (5.1%) 0.382
Diabetes 11 (17.5%) 13 (16.5%) 1.000
Active malignancy 3 (4.8%) 2 (2.5%) 0.655
Regularly visiting clinics and/or hospitals for:
Any disease 56 (88.9%) 71 (89.9%) 1.000
Internal disease 51 (81%) 67 (84.8%) 0.653
Use of systemic steroid and/or immunosuppressant 0 (0%) 5 (6.3%) 0.066
Receipt of PPSV23 notice from municipality 59 (93.7%) 51 (64.6%) <0.001
Reason for visiting our hospital
(radiographic abnormality a)
26 (41.3%) 36 (45.6%) 0.615

Data are presented as median (range) or number of patients (%).

a From annual lung cancer screening or medical check